Conditioned blocking and schizophrenia: a replication and study of the role of symptoms, age, onset-age of psychosis and illness-duration

Schizophrenia Research
S BenderG Sartory

Abstract

Measures of selective attention processing like latent inhibition (LI) and conditioned blocking (CB) are disturbed in some patients with schizophrenia. [LI is the delay in learning about the associations of a stimulus that has been associated with no event (versus de novo learning); CB is the delay in learning the associations of a stimulus-component when the other component has already started to acquire these associations.] We proposed: (1) to replicate the reported decreases of CB in patients without paranoid-hallucinatory symptoms; (2) to see if CB depends on the age of illness-onset and its duration, as reported for LI. We studied 101 young and old, acute and chronically ill patients with schizophrenia, of whom 62 learned a modified 'mouse-in-house' CB task, and compared them with 62 healthy controls matched for age, education and socio-economic background. CB was more evident in patients with a diagnosis of paranoid schizophrenia than other subtypes. An unusual persistence of high CB scores through testing was associated with productive symptoms (including positive thought disorder). Reduced CB related to the expression of (a) Schneider's first rank symptoms of ideas-of-reference and (b) to negative symptoms like poor rap...Continue Reading

References

Apr 1, 1977·Journal of Comparative and Physiological Psychology·P R Solomon
Feb 1, 1978·Behavioral Biology·E J RickertJ French
Nov 1, 1992·Biological Psychiatry·S H JonesD R Hemsley
Feb 1, 1990·British Journal of Psychology·S H JonesD R Hemsley
May 1, 1989·The British Journal of Psychiatry : the Journal of Mental Science·T R Barnes
Jan 1, 1989·European Archives of Psychiatry and Neurological Sciences·G Heim
Oct 1, 1988·The Journal of Nervous and Mental Disease·I BaruchJ A Gray
Jul 1, 1984·Pharmacology, Biochemistry, and Behavior·P A Caza
May 1, 1996·Schizophrenia Research·A L HoffJ G Csernansky
Jan 1, 1997·Journal of Psychopharmacology·N S GrayD R Hemsley
Mar 28, 1998·Schizophrenia Research·P G NestorR W McCarley
Mar 31, 1998·The British Journal of Psychiatry : the Journal of Mental Science·M WeisbrodM Spitzer
Apr 16, 1998·Journal of Child Psychology and Psychiatry, and Allied Disciplines·L K Jacobsen, J L Rapoport
Jun 5, 1998·Schizophrenia Bulletin·J A Gray
Jun 17, 1998·Psychological Medicine·J D StirlingN Quraishi
Aug 26, 1998·Acta Psychiatrica Scandinavica·D V JesteR K Heaton
Nov 24, 1998·Schizophrenia Research·J Addington, D Addington
Jan 11, 2000·Journal of Psychiatric Research·W T CarpenterR W Buchanan
Sep 1, 1998·Cognitive Neuropsychology·M Jahanshahi

❮ Previous
Next ❯

Citations

Jul 5, 2003·Journal of Psychiatric Research·P M MoranM A Reveley
May 29, 2010·The Quarterly Journal of Experimental Psychology : QJEP·Mark Haselgrove, Lisa H Evans
Jul 10, 2003·Developmental Neuropsychology·A E Crookes, P M Moran
Jan 1, 2016·British Journal of Psychology·Mark HaselgroveSimon Killcross
Feb 9, 2010·Psychiatry Research·M E Le PelleyCharlotte Sonia Morris
Sep 4, 2007·Progress in Neuro-psychopharmacology & Biological Psychiatry·P M MoranM A Reveley
Nov 23, 2016·The Quarterly Journal of Experimental Psychology : QJEP·David LuqueMike E Le Pelley
Jun 27, 2007·Journal of Psychopharmacology·P R CorlettP C Fletcher
Jul 13, 2017·Cognitive Neuropsychiatry·Clara S HumpstonDavid E J Linden
Oct 31, 2002·Human Psychopharmacology·Robert D OadesMarie Luise Rao
Oct 1, 2021·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Samuel J MillardMelissa J Sharpe

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here